|
|
These documents are available in Adobe Acrobat� (PDF) format and require the Acrobat� Reader to view and print. To print these documents, download and decompress the files listed under "Download Documents." To browse online interactively, click any entry under "Table of Contents."
Download Documents
Acrobat PDF Files, ZIP Compressed
(File Size: 34 MB. Estimated download time: 3 hours at 28.8 baud, 40 minutes via dual-channel ISDN)
(Requires PKUNZIP� or WinZIP� to decompress, Adobe Acrobat� Reader to view)
Browse Online Table of Contents
Cover and Introduction |
Preface |
Executive Summary |
I. |
|
The Promise of Vaccines |
II. |
|
The Mission of the National Vaccine Program and Purpose of the
National Vaccine Plan |
III. |
|
Disease Prevention Through Vaccine Development and Immunization |
IV. |
|
The Goals, Objectives, and Strategies of the National Vaccine Plan |
V. |
|
Microbial Threats to Health and Global Collaboration Against
Infectious Diseases |
VI. |
|
The Status of Vaccine Development -- 1993 |
VII. |
|
The Status of Immunization - 1993 |
VIII. |
|
Development, Licensure, Recommendations for Use, and Postmarketing
Surveillance of Vaccines |
IX. |
|
Priorities for FY 1994 and FY 1995 |
X. |
|
Coordination |
XI. |
|
Overview of Investment and Resource Allocation |
XII. |
|
Predicted Outcomes of the National Vaccine Plan |
References |
|
Appendixes |
1. |
|
Statutory Basis for the National Vaccine Plan: Title XXI of the
Public Health Service Act (P.L. 99-660) |
2. |
|
Major Federal Organizations Responsible for Vaccine- and
lmmunization-Related Activities |
3. |
|
List of Participants in the Development of the National Vaccine
Plan |
4. |
|
Centers for Disease Control and Prevention, �Addressing Emerging
Infectious Disease Threats to Health: A Prevention Strategy for the United States�
(Excerpts) |
5. |
|
Licensed Vaccines Currently Distributed in the United States |
6. |
|
National Institute of Allergy and Infectious Diseases, �NIAID
Blue Ribbon Panel on Vaccine Research, March 26, 1993: Summary� |
7. |
|
Reported Cases of Vaccine-Preventable Diseases |
8. |
|
Measles Cases, 1989-1991 |
9. |
|
The Childhood Immunization Initiative: Purpose and Targets |
10. |
|
Centers for Disease Control and Prevention, �Childhood
Immunization Initiative Action Plan� |
11. |
|
Summary Excerpts from Benefit/Cost Studies of Immunization |
12. |
|
Acronyms and Abbreviations Used in the Plan |
|
Illustrations |
Table 1: |
Changes in the incidence of vaccine-preventable disease in the
United States |
Table 2: |
Estimates of current vaccine coverage or immunity among American
adults |
Table 3: |
Estimated effect of full use of vaccines currently recommended for
adults |
Table 4: |
Benefit/cost ratios of immunization for measles, mumps, and
rubella |
Table 5: |
Federal appropriations for vaccine development and immunization
programs, FY 1991 to FY 1994 |
Table 6: |
Number of cases reported in the United States in 1992-1993 for
diseases preventable by routine childhood vaccination, and CII targets for 1996 |
Table 7: |
Vaccination coverage targets of CII by vaccine and year |
Table 8: |
Coverage of the Childhood Immunization Initiative in the National
Vaccine Plan
|
|